Edition:
United States

Galenica AG (GALE.S)

GALE.S on Swiss Exchange

48.45CHF
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
CHF48.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
126,536
52-wk High
CHF49.15
52-wk Low
CHF41.80

Latest Key Developments (Source: Significant Developments)

Galenica H1 EBIT up 17.6 pct to CHF 71.5 mln‍​
Tuesday, 8 Aug 2017 12:59am EDT 

Aug 8 (Reuters) - GALENICA AG ::H1 EBIT ROSE BY 17.6% TO CHF 71.5 MILLION‍​.NET SALES INCREASED IN A CHALLENGING MARKET ENVIRONMENT BY 6.8% TO CHF 1,587.5 MILLION IN THE FIRST HALF OF 2017.H1 PROFIT OF CHF 57.9 MILLION.ON A COMPARABLE BASIS (EXCLUDING THE EFFECTS OF IAS 19), NET PROFIT WAS CHF 62.1 MILLION.MANAGEMENT IS CONFIDENT OF ACHIEVING THE AMBITIOUS TARGETS FOR 2017.THE OUTLOOK REGARDING DIVIDENDS ALSO REMAINS UNCHANGED.  Full Article

Galenica issues fixed-interest bonds totalling CHF 380 million
Tuesday, 30 May 2017 07:31am EDT 

May 30 (Reuters) - Galenica AG ::ISSUED FIXED-INTEREST BONDS TOTALLING CHF 380 MILLION FOR THE PURPOSE OF LONG-TERM FINANCING AT ATTRACTIVE CONDITIONS.ISSUE IS TO REFINANCE THE BRIDGE LOAN GRANTED IN THE COURSE OF THE IPO.TWO TRANCHES: INTERMEDIATE TRANCHE OF CHF 200 MILLION AT 0.50% COUPON MATURING AFTER 6 YEARS IN JUNE 2023 AND LONGER TRANCHE OF CHF 180 MILLION AT 1.00% COUPON MATURING AFTER 9.5 YEARS IN DEC. 2026.  Full Article

Galenica: Full exercise of over-allotment option of Galenica Sante IPO
Wednesday, 12 Apr 2017 12:58am EDT 

Galenica AG :Joint global coordinators, acting on behalf of the syndicate banks, have exercised the over-allotment option in full of Galenica Sante IPO.  Full Article

BRIEF-Galenica H1 EBIT up 17.6 pct to CHF 71.5 mln‍​

* NET SALES INCREASED IN A CHALLENGING MARKET ENVIRONMENT BY 6.8% TO CHF 1,587.5 MILLION IN THE FIRST HALF OF 2017